RWP
PRPH

RWA Wealth Partners’s ProPhase Labs PRPH Stock Holding History

RWA Wealth Partners’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,200
Closed -$92K – 578
2024
Q2 		$92K Buy
+2,200
New +$115K ﹤0.01% 535

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RWA Wealth Partners's PRPH Position: Q3 2024 in Review

RWA Wealth Partners sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 2,200 shares — an estimated $92K sold.

RWA Wealth Partners first reported a position in PRPH in Q2 2024 and held it in 1 quarter. The position peaked at $92K in Q2 2024. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • RWA Wealth Partners reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • RWA Wealth Partners sold 2,200 ProPhase Labs shares in Q3 2024, an estimated $92K.
  • RWA Wealth Partners first reported a position in ProPhase Labs in Q2 2024 and held it in 1 quarter.
  • RWA Wealth Partners's ProPhase Labs position peaked at $92K in Q2 2024.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on RWA Wealth Partners's 13F filing for Q3 2024, filed 8 Nov 2024.